Sunday, August 16, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesHugel Posts Record H1 on Toxin Surge—Overseas Growth AcceleratestodayMarketHugel Posts Record H1 Revenue on Overseas Toxin Surge3 days agoDevices & TechApyx: GLP-1 Boom Is Fueling Renuvion DemandtodayMarketMedytox Q2 Sales Up 11%, Operating Profit Down 25%3 days agoInjectablesGalderma Wins EU Nod for Restylane ShaypeyesterdayBusiness & M&AEstablishment Labs Raises 2026 Revenue Guidance2 days agoDevices & TechMerz Ultherapy PRIME Clears FDA for Knee Skin LaxityyesterdayBusiness & M&ABeauty Health Q2 Earnings: Device Demand Steady2 days agoInjectablesHugel Debuts Thechaum Signature with Reduced CrosslinkeryesterdayDevices & TechAlma Launches TitaniumLift™ Multi-Depth RF Protocol2 days agoInjectablesGLP-1 Boom Exposed Filler Limitations—Here's WhyyesterdayInjectablesGalderma Chief: Start GLP-1 Patients on Skin Care First2 days ago
Trade & Tariffs

Section 301

The trade tool for retaliating against unfair foreign practices, the legal engine behind major China tariffs.

Also known as: Section 301 of the Trade Act, Unfair Trade Practices Tariffs

What it is
Section 301 of the Trade Act of 1974 lets the U.S. Trade Representative investigate and retaliate against foreign trade practices deemed unfair or discriminatory. Remedies include tariffs on targeted imports. It has been the basis for sweeping China tariff lists.
What it does
Section 301 actions target specific product lists, so investors read the lists to find exposed importers and advantaged domestic rivals. Exclusion processes and list revisions create ongoing catalysts. Supply-chain shifts follow as firms reroute sourcing.
The evidence
Section 301 China tariff lists reshaped sourcing decisions and pressured import-heavy sectors like consumer electronics and machinery.
Best for
China-import-exposed retailers and hardware names; domestic substitutes vary by list.
Pairs well with
tariff, section-232, export-controls
Use cautiously with
Exclusion grants and list changes can reverse exposure; treating a list as permanent misses the constant revisions.
Cautions
Tariff costs are often passed through or absorbed unevenly, so margin impact is company-specific.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo